Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
Background: The optimal therapeutic strategy for coronary intervention in edge in-stent restenosis (edge ISR) remains less well-defined. Aim: The aim of this study was to assess 12-month outcomes of re-stenting using drug-eluting stents (DESs) versus using drug-eluting balloon (DEB) for managing cor...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of Indian College of Cardiology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jicc.jicc_36_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841545168789962752 |
---|---|
author | Yasser Gaber Metwally Khaled Yehia Elnady Tarek Abd El-Ghaffar Eman Hesham Seddik Ahmed Shaker Fathy Mohamed Swailem |
author_facet | Yasser Gaber Metwally Khaled Yehia Elnady Tarek Abd El-Ghaffar Eman Hesham Seddik Ahmed Shaker Fathy Mohamed Swailem |
author_sort | Yasser Gaber Metwally |
collection | DOAJ |
description | Background:
The optimal therapeutic strategy for coronary intervention in edge in-stent restenosis (edge ISR) remains less well-defined.
Aim:
The aim of this study was to assess 12-month outcomes of re-stenting using drug-eluting stents (DESs) versus using drug-eluting balloon (DEB) for managing coronary edge ISR.
Patients and Methods:
One hundred and four patients with edge ISR were randomly assigned to either DES or DEB. The primary endpoint was stent failure at 12-month follow-up.
Results:
Significantly lower target vessel revascularization among the DEB group compared to restenting group, (7.7% vs. 23.1%, P = 0.04). Likewise, target vessel-related myocardial infarction rate was significantly lower among the DEB group than restenting (5.7% vs. 23.1%, P = 0.04). On the other hand, there were no significant differences in the rates of deaths or restenosis between the two groups.
Conclusion:
The DEB is superior to the DES with better both safety and efficacy. |
format | Article |
id | doaj-art-f36d46cb66ab4be3882f9216b9f44ffc |
institution | Kabale University |
issn | 1561-8811 2213-3615 |
language | English |
publishDate | 2024-12-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Journal of Indian College of Cardiology |
spelling | doaj-art-f36d46cb66ab4be3882f9216b9f44ffc2025-01-12T10:26:24ZengWolters Kluwer Medknow PublicationsJournal of Indian College of Cardiology1561-88112213-36152024-12-0114411411810.4103/jicc.jicc_36_24Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting BalloonYasser Gaber MetwallyKhaled Yehia ElnadyTarek Abd El-GhaffarEman Hesham SeddikAhmed ShakerFathy Mohamed SwailemBackground: The optimal therapeutic strategy for coronary intervention in edge in-stent restenosis (edge ISR) remains less well-defined. Aim: The aim of this study was to assess 12-month outcomes of re-stenting using drug-eluting stents (DESs) versus using drug-eluting balloon (DEB) for managing coronary edge ISR. Patients and Methods: One hundred and four patients with edge ISR were randomly assigned to either DES or DEB. The primary endpoint was stent failure at 12-month follow-up. Results: Significantly lower target vessel revascularization among the DEB group compared to restenting group, (7.7% vs. 23.1%, P = 0.04). Likewise, target vessel-related myocardial infarction rate was significantly lower among the DEB group than restenting (5.7% vs. 23.1%, P = 0.04). On the other hand, there were no significant differences in the rates of deaths or restenosis between the two groups. Conclusion: The DEB is superior to the DES with better both safety and efficacy.https://journals.lww.com/10.4103/jicc.jicc_36_24coronary edgeeluting ballooneluting stentstent restenosis |
spellingShingle | Yasser Gaber Metwally Khaled Yehia Elnady Tarek Abd El-Ghaffar Eman Hesham Seddik Ahmed Shaker Fathy Mohamed Swailem Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon Journal of Indian College of Cardiology coronary edge eluting balloon eluting stent stent restenosis |
title | Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon |
title_full | Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon |
title_fullStr | Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon |
title_full_unstemmed | Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon |
title_short | Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon |
title_sort | outcome of coronary edge in stent restenosis management by restenting versus drug eluting balloon |
topic | coronary edge eluting balloon eluting stent stent restenosis |
url | https://journals.lww.com/10.4103/jicc.jicc_36_24 |
work_keys_str_mv | AT yassergabermetwally outcomeofcoronaryedgeinstentrestenosismanagementbyrestentingversusdrugelutingballoon AT khaledyehiaelnady outcomeofcoronaryedgeinstentrestenosismanagementbyrestentingversusdrugelutingballoon AT tarekabdelghaffar outcomeofcoronaryedgeinstentrestenosismanagementbyrestentingversusdrugelutingballoon AT emanheshamseddik outcomeofcoronaryedgeinstentrestenosismanagementbyrestentingversusdrugelutingballoon AT ahmedshaker outcomeofcoronaryedgeinstentrestenosismanagementbyrestentingversusdrugelutingballoon AT fathymohamedswailem outcomeofcoronaryedgeinstentrestenosismanagementbyrestentingversusdrugelutingballoon |